Antibiotice Ia (ATB) — Cash Flow Quality Index
Antibiotice Ia (ATB) has a Cash Flow Quality Index of 6.40x as of June 2026. Operating cash flow of RON18.71 Million exceeds net income of RON2.92 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Antibiotice Ia service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Antibiotice Ia Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Antibiotice Ia across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Antibiotice Ia (ATB) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Cash Flow Quality Index for Antibiotice Ia (2022–2025)
Year-by-year earnings quality comparison for Antibiotice Ia. For the full cash flow conversion analysis, see ATB cash flow conversion.
| Year | Quality Index | Operating CF (RON) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.40x | RON72.44 Million | RON51.77 Million | ▲ +46.2% |
| 2024 | 0.96x | RON95.15 Million | RON99.42 Million | ▼ -36.6% |
| 2023 | 1.51x | RON122.46 Million | RON81.09 Million | ▼ -49.7% |
| 2022 | 3.00x | RON115.66 Million | RON38.51 Million | — |